内分析运动对接受血液透析的患者认知的影响:随机对照试验的最新系统审查
Andreas Mavrommatis1,2, Nicos Mitsides3, Myrtani Pieri1,2
1Department of Life Sciences, School of Life and Health Sciences, University of Nicosia, 2417 Nicosia, Cyprus.
Healthcare (Basel, Switzerland)
|December 11, 2025
概括
透析内运动训练 (IET) 显著改善了血液透析患者的认知功能. 这种干预增强了全球认知和执行功能和处理速度等特定领域,为认知健康提供了有前途的方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 神经科学是一个神经科学.
- 运动生理学 运动生理学
背景情况:
- 与普通人群相比,血液透析患者的认知障碍率更高.
- 血液透析患者的认知缺陷影响生活质量和治疗坚持.
- 内部分析性运动训练 (IET) 是一个潜在的干预措施,以减轻认知能力下降.
研究的目的:
- 系统地审查和综合有关IET对血液透析患者认知功能的影响的证据.
- 评估IET对全球认知和特定认知领域的影响.
- 为了确定最佳的IET参数用于认知增强.
主要方法:
- 在PubMed,Scopus和EBSCO进行了系统的文献搜索,直到2025年8月.
- 包括随机对照试验 (RCT),专注于IET和血液透析患者的认知结果.
- 通过Jadad Scale和NHLBI工具评估研究的偏差风险和方法质量.
主要成果:
- 包括7项涉及332名血液透析患者的RCT.
- 根据MoCA和MMSE的测量,IET显著改善了全球认知功能.
- 有氧运动干预措施在执行功能,处理速度和警觉性方面显著改善.
结论:
- IET是一种有效的干预措施,用于改善血液透析患者的认知功能.
- 在这个人群中,IET可能会提供保护性好处,防止未来的认知能力下降.
- 为了指导临床实践,需要进行更多具有标准化报告的大型RCT.
相关概念视频
Hemodialysis III: Nursing Management
687
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
687
Heart Failure Drugs: Diuretics
764
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
764
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
192
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
192
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
879
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879
Hemodialysis II: Procedure and Complications
567
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
567
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
217
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
217


